GP VI-Mediated Platelet Activation and Procoagulant Activity Aggravate Inflammation and Aortic Wall Remodeling in Abdominal Aortic Aneurysm

Arterioscler Thromb Vasc Biol. 2024 Nov;44(11):2294-2317. doi: 10.1161/ATVBAHA.123.320615. Epub 2024 Aug 29.

Abstract

Background: Platelets play an important role in cardiovascular and cerebrovascular diseases. Abdominal aortic aneurysm (AAA) is a highly lethal, atherosclerosis-related disease with characteristic features of progressive dilatation of the abdominal aorta and degradation of the vessel wall, accompanied by chronic inflammation. Platelet activation and procoagulant activity play a decisive role in the AAA pathology as they might trigger AAA development in both mice and humans.

Methods: The present study investigated the impact of the major platelet collagen receptor GP (platelet glycoprotein) VI in pathophysiological processes underlying AAA initiation and progression. For experimental AAA induction in mice, PPE (porcine pancreatic elastase) and the external PPE model were used.

Results: Genetic deletion of GP VI offered protection of mice against aortic diameter expansion in experimental AAA. Mechanistically, GP VI deficiency resulted in decreased inflammation with reduced infiltration of neutrophils and platelets into the aortic wall. Furthermore, remodeling of the aortic wall was improved in the absence of GP VI, as indicated by reduced MMP (matrix metalloproteinase)-2/9 and OPN (osteopontin) plasma levels and an enhanced α-SMA (α-smooth muscle actin) content within the aortic wall, accompanied by reduced cell apoptosis. Consequently, an elevation in intima/media thickness and elastin content was observed in GP VI-deficient PPE mice, resulting in a significantly reduced aortic diameter expansion and reduced aneurysm incidence. In patients with AAA, enhanced plasma levels of soluble GP VI and fibrin, as well as fibrin accumulation within the intraluminal thrombus might serve as new biomarkers to detect AAA early. Moreover, we hypothesize that GP VI might play a role in procoagulant activity and thrombus stabilization via binding to fibrin.

Conclusions: In conclusion, our results emphasize the potential need for a GP VI-targeted antiplatelet therapy to reduce AAA initiation and progression, as well as to protect patients with AAA from aortic rupture.

Keywords: aortic aneurysm, abdominal; aortic rupture; blood platelets; dilatation; inflammation.

MeSH terms

  • Actins / metabolism
  • Animals
  • Aorta, Abdominal* / metabolism
  • Aorta, Abdominal* / pathology
  • Aortic Aneurysm, Abdominal* / blood
  • Aortic Aneurysm, Abdominal* / metabolism
  • Aortic Aneurysm, Abdominal* / pathology
  • Aortitis / blood
  • Aortitis / genetics
  • Aortitis / metabolism
  • Aortitis / pathology
  • Apoptosis
  • Blood Coagulation
  • Blood Platelets* / metabolism
  • Dilatation, Pathologic
  • Disease Models, Animal
  • Humans
  • Male
  • Matrix Metalloproteinase 2* / metabolism
  • Matrix Metalloproteinase 9* / blood
  • Matrix Metalloproteinase 9* / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Osteopontin* / blood
  • Osteopontin* / genetics
  • Osteopontin* / metabolism
  • Pancreatic Elastase
  • Platelet Activation*
  • Platelet Membrane Glycoproteins* / genetics
  • Platelet Membrane Glycoproteins* / metabolism
  • Signal Transduction
  • Vascular Remodeling*

Substances

  • Acta2 protein, mouse
  • Actins
  • Matrix Metalloproteinase 2
  • Matrix Metalloproteinase 9
  • Mmp2 protein, mouse
  • Mmp9 protein, mouse
  • Osteopontin
  • Pancreatic Elastase
  • platelet membrane glycoprotein VI
  • Platelet Membrane Glycoproteins
  • Spp1 protein, mouse